SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-18-000571
Filing Date
2018-12-13
Accepted
2018-12-13 16:35:22
Documents
4
Period of Report
2018-12-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 12-13-2018 form_8-k.htm 8-K 11248
2 LETTER OF INTENT - DIABETES RELIEF LLC ex_99-1.htm EX-99 27062
3 PRESS RELEASE - DECEMBER 13, 2018 ex_99-2.htm EX-99 3735
4 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-18-000571.txt   57628
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 181233620
SIC: 2834 Pharmaceutical Preparations